Date: 2017-06-13
Type of information: Nomination
Compound:
Company: Audentes Therapeutics (USA - CA)
Therapeutic area: Rare diseases - Genetic diseases
Type agreement: nomination
Action mechanism:
Disease:
Details:
- • On June 13, 2017, Audentes Therapeutics announced the appointment of Jennifer Jarrett to its board of directors. Ms. Jarrett serves as the Chief Financial and Business Officer of Arcus Biosciences. She served as Chief Financial Officer of Medivation until the company's purchase by Pfizer in 2016. Previously, Ms. Jarrett served as Managing Director at Citigroup, where she was responsible for building and managing Citigroup's West Coast life sciences investment banking practice. Prior to Citigroup, Ms. Jarrett was a Managing Director in Credit Suisse's Health Care Group focused on the biotechnology sector. She earned a bachelor's degree in economics, Cum Laude, from Dartmouth College and holds a masters of business administration from Stanford Graduate School of Business.
Financial terms:
Latest news:
Is general: Yes
